Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-1,190
Closed -$533K 1732
2025
Q3
$533K Buy
+1,190
New +$539K 0.03% 535
2025
Q2
Sell
-1,104
Closed -$679K 1528
2025
Q1
$679K Buy
1,104
+132
+14% +$75K 0.04% 397
2024
Q4
$515K Buy
+972
New +$548K 0.03% 495
2024
Q1
Sell
-1,048
Closed -$612K 1482
2023
Q4
$612K Buy
+1,048
New +$586K 0.05% 337
2023
Q3
Sell
-1,699
Closed -$920K 1370
2023
Q2
$920K Buy
+1,699
New +$929K 0.07% 230
2020
Q3
Sell
-1,446
Closed -$652K 1114
2020
Q2
$652K Buy
+1,446
New +$646K 0.08% 285
2019
Q2
Sell
-2,316
Closed -$741K 1489
2019
Q1
$741K Buy
+2,316
New +$711K 0.04% 399
2018
Q2
Sell
-3,737
Closed -$1.02M 2016
2018
Q1
$1.02M Buy
+3,737
New +$990K 0.05% 355

Other funds holding CHE

Virtu Financial's CHE Position: Q4 2025 in Review

Virtu Financial sold out of Chemed (CHE) in Q4 2025, closing a stake of 1,190 shares — an estimated $533K sold.

Virtu Financial first reported a position in CHE in Q1 2018 and held it in 8 quarters. The position peaked at $1.02M in Q1 2018. 516 funds tracked by Wall St. Rank hold CHE as of Q4 2025.

  • Virtu Financial reported no remaining Chemed position as of Q4 2025 after selling out during the quarter.
  • Virtu Financial sold 1,190 Chemed shares in Q4 2025, an estimated $533K.
  • Virtu Financial first reported a position in Chemed in Q1 2018 and held it in 8 quarters.
  • Virtu Financial's Chemed position peaked at $1.02M in Q1 2018.
  • 516 funds tracked by Wall St. Rank held Chemed as of Q4 2025.

Based on Virtu Financial's 13F filing for Q4 2025, filed 23 Feb 2026.